About Alvéole
Alvéole is a Healthcare company based in Paris (France) founded in 2010. In vitro cell microenvironment models are developed using specialized devices. It operates on a Direct-to-Consumer (D2C) model. Alvéole has raised $1.16 million across 2 funding rounds from investors including Le Village by CA and Le Quattrocento. Its chief executive, as recorded, is Romuald Vally. Alvéole offers products and services including PRIMO, LEONARDO, PLPP, and PDMS Stencil. Its focus areas include Biotechnology and Bioengineering.
Company details
Alvéole is engaged in the development of bioengineering tools aimed at accelerating cell biology research. The company offers a range of products, including PRIMO for micropatterning and smart cell culture substrates, alongside complementary tools like LEONARDO software and PDMS stencils. Solutions provided by Alvéole are utilized by academic laboratories to enhance reliability and reproducibility in cell models. The focus is placed on user needs, ensuring innovations are tailored to practical research applications within the biotechnology sector.
- Headquarters Paris, France
- SectorsHealthcare
- Phone•••• ••••
- Website alveolelab.com
- Social LinkedIn X YouTube
- Total Equity Funding$1.16M (USD)
in 2 rounds
- Latest Funding Round$1.16M (USD), Seed
Oct 2018
- InvestorsLe Village by CA
& 1 more
Products & Services of Alvéole
Alvéole offers a comprehensive portfolio of products and services, including PRIMO, LEONARDO, PLPP, and PDMS Stencil.
Bioengineering tool for creating smart cell culture substrates.
Software for enhancing bioengineering and micropatterning processes.
Reagent used in bioengineering for cell culture applications.
Tool for structuring hydrogels in cell biology research.
Apps and channels of Alvéole
its YouTube channel Alvéole, Take care of your cells - alveolelab has 628 subscribers and 30 videos.
Videos from Alvéole
The most watched videos on Alvéole's YouTube channel, Alvéole, Take care of your cells - alveolelab (628 subscribers). Click a video to play it here.
Funding Insights of Alvéole
Alvéole has successfully raised a total of $1.16M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.16 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.16M
- Total Rounds 2
- Last Round Seed — $1.16M
- Investors Count 2
All 2 funding rounds of Alvéole with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2018 | $1.16M | Seed | – | Quattrocento | – |
| Jul 2018 | Seed | – | Le Village by CA | – |
2 investors in total: 2 institutional.
Investors in Alvéole
Alvéole has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Le Village by CA and Le Quattrocento.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startups are accelerated sector-agnostically by Le Village by CA. | 2014 | levillagebyca.com | Paris, France | |
Promising academic inventions are developed into life science startups. | 2010 | lequattrocento.com | Paris, France |
Investor details for Alvéole
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Alvéole
1 people are tracked at Alvéole (1 in leadership).
| Name | Role | Group |
|---|---|---|
Romuald Vally | CEO | Leadership |
Complete people profiles for Alvéole
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Alvéole
3 dated milestones of Alvéole across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Alvéole is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $1.2M.
Web traffic of Alvéole
The website of Alvéole (alveolelab.com) receives about 3.7K visits a month.
- Monthly visits3.7K
Websites whose visitors overlap most with Alvéole. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
alveoleplus.fr | alveoleplus.fr | 100% | #6,983,524 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Alvéole
Alvéole was founded in 2010 and raised its 1st funding round 8 years after it was founded.
Alvéole is headquartered in Paris, France.
Romuald Vally is the CEO of Alvéole, as recorded in our data.
Alvéole is a funded company, having raised a total of $1.16M across 2 funding rounds to date.
Alvéole is engaged in the development of bioengineering tools aimed at accelerating cell biology research. The company offers a range of products, including PRIMO for micropatterning and smart cell culture substrates, alongside complementary tools like LEONARDO software and PDMS stencils. Solutions provided by Alvéole are utilized by academic laboratories to enhance reliability and reproducibility in cell models. The focus is placed on user needs, ensuring innovations are tailored to practical research applications within the biotechnology sector.
Alvéole offers PRIMO, LEONARDO, PLPP, and PDMS Stencil.
Alvéole has 2 investors. Key investors include Le Village by CA, and Le Quattrocento.